Literature DB >> 28384775

Superior Canal Dehiscence Syndrome Affecting 3 Families.

Katherine D Heidenreich1, Paul R Kileny1, Sameer Ahmed1, Hussam K El-Kashlan1, Tori L Melendez2, Gregory J Basura1, Marci M Lesperance2.   

Abstract

Importance: Superior canal dehiscence syndrome (SCDS) is an increasingly recognized cause of hearing loss and vestibular symptoms, but the etiology of this condition remains unknown. Objective: To describe 7 cases of SCDS across 3 families. Design, Setting, and Participants: This retrospective case series included 7 patients from 3 different families treated at a neurotology clinic at a tertiary academic medical center from 2010 to 2014. Patients were referred by other otolaryngologists or were self-referred. Each patient demonstrated unilateral or bilateral SCDS or near dehiscence. Interventions: Clinical evaluation involved body mass index calculation, audiometry, cervical vestibular evoked myogenic potential testing, electrocochleography, and multiplanar computed tomographic (CT) scan of the temporal bones. Zygosity testing was performed on twin siblings. Main Outcomes and Measures: The diagnosis of SCDS was made if bone was absent over the superior semicircular canal on 2 consecutive CT images, in addition to 1 physiologic sign consistent with labyrinthine dehiscence. Near dehiscence was defined as absent bone on only 1 CT image but with symptoms and at least 1 physiologic sign of labyrinthine dehiscence.
Results: A total of 7 patients (5 female and 2 male; age range, 8-49 years) from 3 families underwent evaluation. Family A consisted of 3 adult first-degree relatives, of whom 2 were diagnosed with SCDS and 1 with near dehiscence. Family B included a mother and her child, both of whom were diagnosed with unilateral SCDS. Family C consisted of adult monozygotic twins, each of whom was diagnosed with unilateral SCDS. For all cases, dehiscence was located at the arcuate eminence. Obesity alone did not explain the occurrence of SCDS because 5 of the 7 cases had a body mass index (calculated as weight in kilograms divided by height in meters squared) less than 30.0. Conclusions and Relevance: Superior canal dehiscence syndrome is a rare, often unrecognized condition. This report of 3 multiplex families with SCDS provides evidence in support of a potential genetic contribution to the etiology. Symptomatic first-degree relatives of patients diagnosed with SCDS should be offered evaluation to improve detection of this disorder.

Entities:  

Mesh:

Year:  2017        PMID: 28384775      PMCID: PMC5824203          DOI: 10.1001/jamaoto.2016.4743

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  26 in total

1.  Superior canal dehiscence is not due to cephalic displacement of the labyrinth.

Authors:  Valeria L Potyagaylo; Charley C Della Santina; Lloyd B Minor; John P Carey
Journal:  Ann N Y Acad Sci       Date:  2005-04       Impact factor: 5.691

2.  Acquired superior semicircular canal dehiscence confirmed by sequential CT scans.

Authors:  Ji Seon Bae; Hyun Woo Lim; Yun Suk An; Hong Ju Park
Journal:  Otol Neurotol       Date:  2013-08       Impact factor: 2.311

3.  Prevalence of Cochlear-Facial Dehiscence in a Study of 1,020 Temporal Bone Specimens.

Authors:  Christina H Fang; Sei Yeon Chung; Danielle M Blake; Alejandro Vazquez; Chengrui Li; John P Carey; Howard W Francis; Robert W Jyung
Journal:  Otol Neurotol       Date:  2016-08       Impact factor: 2.311

4.  Genetic factors in otosclerosis.

Authors:  A W Morrison
Journal:  Ann R Coll Surg Engl       Date:  1967-08       Impact factor: 1.891

5.  Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal.

Authors:  L B Minor; D Solomon; J S Zinreich; D S Zee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-03

6.  Air-conducted oVEMPs provide the best separation between intact and superior canal dehiscent labyrinths.

Authors:  Kristen L Janky; Kimanh D Nguyen; Miriam Welgampola; M Geraldine Zuniga; John P Carey
Journal:  Otol Neurotol       Date:  2013-01       Impact factor: 2.311

7.  Semicircular canal dehiscence in the pediatric population.

Authors:  Eunice Y Chen; Angelisa Paladin; Grace Phillips; Molly Raske; Liah Vega; Do Peterson; Kathleen C Y Sie
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-12-16       Impact factor: 1.675

8.  Superior semicircular canal dehiscence presenting as conductive hearing loss without vertigo.

Authors:  Anthony A Mikulec; Michael J McKenna; Mitchell J Ramsey; John J Rosowski; Barbara S Herrmann; Steven D Rauch; Hugh D Curtin; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2004-03       Impact factor: 2.311

9.  High-resolution CT findings suggest a developmental abnormality underlying superior canal dehiscence syndrome.

Authors:  Timo P Hirvonen; Noah Weg; S James Zinreich; Lloyd B Minor
Journal:  Acta Otolaryngol       Date:  2003-05       Impact factor: 1.494

10.  Mutation analysis of Netrin 1 and HMX3 genes in patients with superior semicircular canal dehiscence syndrome.

Authors:  Nikola Roknic; Alexander Huber; Stefan C A Hegemann; Rudolf Häusler; Nicolas Gürtler
Journal:  Acta Otolaryngol       Date:  2012-07-10       Impact factor: 1.494

View more
  3 in total

1.  Minimal invasive resurfacing: an innovative technique for the superior semicircular canal dehiscence. A case series.

Authors:  Fabrizio Salvinelli; Francesca Bonifacio; Claudia Beccaria; Fabio Greco; Valeria Frari; Francesco Iafrati; Maurizio Trivelli
Journal:  J Surg Case Rep       Date:  2022-05-31

Review 2.  Genetic contribution to vestibular diseases.

Authors:  Alvaro Gallego-Martinez; Juan Manuel Espinosa-Sanchez; Jose Antonio Lopez-Escamez
Journal:  J Neurol       Date:  2018-03-26       Impact factor: 4.849

3.  One Genetic Defect and Two Related Entities in Monozygotic Twins: Otosclerosis and Superior Semicircular Canal Near Dehiscence Syndrome.

Authors:  F Ceyda Akin Ocal; Haluk Kavus; Bulent Satar; Davut Pehli van
Journal:  J Audiol Otol       Date:  2021-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.